Adjuvant Chemotherapy for Stage III Colon Cancer
JAMAPublished 6 December 2005
J. Milburn Jessup, Andrew K. Stewart, Frederick L. Greene, Bruce D. Minsky
Citations296
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Adjuvant chemotherapy use has increased from 1990 to 2002 for patients with stage III colon cancer with an associated increase in 5-year survival of 16%.
Abstract
Adjuvant chemotherapy use has increased from 1990 to 2002 for patients with stage III colon cancer with an associated increase in 5-year survival of 16%. The benefit of adjuvant chemotherapy seems to be lower in black patients and high-grade cancers. Women have the same benefit but are less often treated. Elderly patients have the same benefit as younger patients but are less frequently treated. New options for adjuvant therapy in 2004-2005 may further improve the outcome of patients with stage III colon cancer.
Keywords
Medicine
AJCC Cancer Staging Manual
17,372 Citations2016
DefinitionsInternational Classification of Diseases for Oncology
3,826 Citations2020National Cancer Institute
New England Journal of MedicineLevamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
2,245 Citations1990Charles G. Moertel, Thomas R. Fleming +10 more
Adjuvant therapy with levamisole and fluorouracil should be standard treatment for Stage C colon carcinoma, and this approach should be readily adaptable to conventional medical practice.
Journal of Clinical OncologyPooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?
1,015 Citations2004Sharlene Gill, Charles L. Loprinzi +13 more
Patients with high-risk resected colon cancer obtain benefit from FU-based therapy across subsets of age, sex, location, T stage, nodal status, and grade, which may improve patients' and physicians' understanding of the potential benefits of adjuvant therapy.
New England Journal of MedicineA Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
984 Citations2001Daniel J. Sargent, Richard M. Goldberg +7 more
Journal of Clinical OncologySurgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.
699 Citations1989John A. Laurie, C G Moertel +8 more
Whereas both treatment regimens were associated with overall improvements in survival, these improvements reached borderline significance only for stage C patients treated with levamisole plus 5-FU (P = .03).
Journal of Clinical OncologyThe benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.
687 Citations1993Norman Wolmark, Howard E. Rockette +8 more
Treating patients with Dukes' stage B and C carcinoma of the colon with leucovorin-modulated fluorouracil as adjuvant therapy significantly prolongs disease-free survival and results in a significant benefit relative to overall survival.
Journal of Clinical OncologySystematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials
599 Citations2005Carol Townsley, Rita Selby +1 more
Specific clinical trials confined to older patients should be conducted to evaluate tumor biology, treatment tolerability, and the effect of comorbid conditions, and protocol designs need to stratify for age and be less restrictive with respect to exclusions on functional status,Comorbidity, and previous cancers, such that results are generalizable to Older patients.
Journal of Clinical OncologyClinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukes' B and C Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project C-04
494 Citations1999Norman Wolmark, Howard E. Rockette +10 more
In patients with Dukes' B and C carcinoma of the colon, treatment with FU+LV seems to confer a small DFS advantage and a borderline prolongation in overall survival when compared with treatment withFU+LEV.
JNCI Journal of the National Cancer InstituteAge and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer
486 Citations2001Deborah Schrag, Laura D. Cramer +2 more
Age at diagnosis was the strongest determinant of chemotherapy and the age trend remained pronounced after adjustment for potential confounding based on variation in patients' demographic and clinical characteristics and after exclusion of patients with any evident comorbidity.
Journal of Clinical OncologyProspectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
417 Citations1998M. J. OʼConnell, John A. Laurie +13 more
The data suggest that 5-FU plus levamisole for 6 months should not be used in clinical practice, whereas 6 months of treatment with 5-fu plus leucovorin plus lev amisole is effective.
Journal of Clinical OncologyUse of Adjuvant Chemotherapy and Radiation Therapy for Colorectal Cancer in a Population-Based Cohort
309 Citations2003John Z. Ayanian, Alan M. Zaslavsky +9 more
Use of adjuvant therapy for colorectal cancer varies substantially by age, race, marital status, hospital volume, and individual hospital, indicating opportunities to improve care.
Journal of Clinical OncologyAge, Sex, and Racial Differences in the Use of Standard Adjuvant Therapy for Colorectal Cancer
278 Citations2002Arnold L. Potosky, Linda C. Harlan +3 more
British Journal of CancerDihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity
276 Citations1999G. Milano, M C Etienne +4 more
Journal of Clinical OncologySemimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial
259 Citations2003Thierry André, Philippe Colin +12 more
No statistically significant difference could be detected in disease-free or overall survival between the treatment groups or treatment durations, and the data confirm that LVFU2 is less toxic than FULV.
CancerThe National Cancer Data Base report on colon cancer
249 Citations1996J. Milburn Jessup, Lamar S. McGinnis +3 more
The NCDB data suggest an important biologic role for grade of cancer, and that African-Americans and other ethnic groups have the same outcome as non-Hispanic whites but that access to medical care may still be less.
Annals of SurgeryA New TNM Staging Strategy for Node-Positive (Stage III) Colon Cancer
227 Citations2002Frederick L. Greene, Andrew K. Stewart +1 more
Analysis of a large data set supports stratification into three subsets, confirming the benefit of adjuvant chemotherapy in each subgroup, and should be used in the reporting and staging of node-positive colon cancers.
Annals of Internal MedicineSurvival Associated with 5-Fluorouracil–Based Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer
226 Citations2002Vijaya Sundararajan, Nandita Mitra +4 more
The effect of 5-fubased adjuvant chemotherapy on survival in a population-based sample of elderly patients with node-positive colon cancer yielded survival benefits similar to those observed in younger patients, and results remained robust in a careful sensitivity analysis.
JNCI Journal of the National Cancer InstituteValidity of Cancer Registry Data for Measuring the Quality of Breast Cancer Care
215 Citations2002Jennifer L. Malin, Katherine L. Kahn +4 more
Cancer registry data for quality measurement may not be valid for all care settings, but registries could provide the infrastructure for collecting data on the quality of cancer care and it is urged that funding be increased to augment data collection by cancer registries.
PubMed5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites.
183 Citations2002Temitope O. Keku, Robert C. Millikan +6 more
Variation at MTHFR codon 1298 (within the COOH-terminal region) may be more important for colon cancer than variation at codon 677 (NH(2)-terminal regions, and in populations where folate intake is low, wild-type MTH FR activity may increase risk for coloncancer.
JNCI Journal of the National Cancer InstituteEthnic Neutropenia and Treatment Delay in African American Women Undergoing Chemotherapy for Early-Stage Breast Cancer
155 Citations2003Dawn L. Hershman, Mitchell Weinberg +6 more
The lower baseline WBC counts and longer duration of treatment for early-stage breast cancer in African American women compared with those in white women result in lower dose intensity of treatment, possibly contributing to observed racial differences in breast cancer survival.
JNCI Journal of the National Cancer InstituteOutcomes and Toxicity in African-American and Caucasian Patients in a Randomized Adjuvant Chemotherapy Trial for Colon Cancer
147 Citations2002Andrea M. McCollum
This study examined survival and toxic effects among African-American and Caucasian patients enrolled in a large, randomized phase III trial of adjuvant chemotherapy for resected colon cancer and found similar 5-year DFS and OS in African-Americans and Caucasians with stage II and III colon cancer.
Journal of Clinical OncologyDeveloping a System to Assess the Quality of Cancer Care: ASCO's National Initiative on Cancer Care Quality
146 Citations2004Eric C. Schneider, Arnold M. Epstein +3 more
This work presents a meta-analyses of the immune system’s response to infectious disease and shows clear patterns of decline in the number of vaccinated individuals and in the severity of their disease and the incidence of adverse events.
JNCI Journal of the National Cancer InstituteOutcomes Among African-Americans and Caucasians in Colon Cancer Adjuvant Therapy Trials: Findings From the National Surgical Adjuvant Breast and Bowel Project
131 Citations1999James J. Dignam, Linda H. Colangelo +5 more
While the overall survival prognosis was less favorable for African-Americans compared with Caucasians in these trials, other outcomes measured were considerably more similar than those seen in the population at large, suggesting that earlier detection and adjuvant therapy could appreciably improve colon cancer prognosis forAfrican-Americans.
PubMedManagement and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer.
130 Citations1995Robert W. Beart, G Steele +4 more
This study suggests evolving patterns of evaluation, increased preservation of continence, and improved but varying survival among ethnic groups and suggests that survival as measured across these 943 hospitals may be lower than that attained at some individual centers.
CancerA comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results program
116 Citations1997C Mettlin, Herman R. Menck +2 more
The purpose of this investigation was to compare the aggregate NCDB data for selected cancer types from a given year with comparable SEER data.
Archives of SurgeryStage III Colon Cancers
108 Citations2000Timothy R. Mahoney
A large group of elderly patients who had been surgically treated for colon cancer and who were eligible for adjuvant chemotherapy either were not referred for treatment or refused treatment, suggesting a bias on the part of surgeons, primary care physicians, and patients against the use of chemotherapy in elderly patients.
CancerThe national cancer data base report on colorectal cancer
95 Citations1994Glenn Steele
The most current 1993 National Cancer Data Base (NCDB) data on colorectal cancer data are reported herein, which show time trends in stage of disease, treatment patterns, and survival for coloreCTal cancer.
CancerThe National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985-1995
92 Citations1998J. Milburn Jessup, Andrew K. Stewart +1 more
The Commission on Cancer data from the National Cancer Data Base examining current time trends in stage of disease, treatment patterns, and survival relating to patients with rectal adenocarcinoma are described in this report.
CancerThe growth and maturation of the national cancer data base
74 Citations1997Herman R. Menck, Myles P. Cunningham +5 more
CancerSocioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum
66 Citations2002Juliet VanEenwyk, Joseph S. Campo +1 more
The current study examined the relationship between socioeconomic and demographic factors and type of treatment for carcinomas of the colon and rectum and recommended surgery followed by adjuvant chemo‐ and/or radiotherapy for Stage III colon and Stages II and III rectal carcinomas.
GastroenterologyAlterations in exon 4 of the p53 gene in gastric carcinoma
64 Citations2000Tara Shepherd, Dawn Tolbert +9 more
There are several exon 4 alterations in gastric cancers, the most common change is the codon 72 polymorphism, the genotype of which differs significantly with race, and the more common arg/arg genotype in whites may explain why whites are more prone to develop cardiac cancer, whereas the moreCommon proline allele in blacks may explainWhy they are moreprone to develop antral cancers.
Journal of Chronic DiseasesRace, socioeconomic status, and other prognostic factors for survival from colo-rectal cancer
63 Citations1987Hari H. Dayal, Lincoln Polissar +2 more
The race effect was statistically significant in all multivariate models and only race was significant in models that considered both race and SES.
CA A Cancer Journal for CliniciansClinical highlights from the National Cancer Data Base, 1999
53 Citations1999Amy M. Fremgen, Kirby I. Bland +5 more
The National Cancer Data Base (NCDB), a joint project of the Commission on Cancer of the American College of Surgeons and the American Cancer Society, collects and analyzes data from a wide variety of sources throughout the United States, including small community hospitals.
CancerRegional diversity and breadth of the National Cancer Data Base
22 Citations1998Herman R. Menck, Kirby I. Bland +4 more
The most current (1995) data is described, which provides a comparative summary of patient care that is used by participating hospitals and communities for self‐assessment.
British Journal of CancerAdjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice
17 Citations2001Christine Bouchardy, P-E Queneau +7 more
It is shown that chemotherapy is probably not optimally utilised in Switzerland, particularly among the elderly, however, strong beneficial effect of adjuvant chemotherapy on stage III CC can be achieved in routine practice.